SM

Stephen Carl McKeown

NA Novartis Ag: 5 patents #875 of 5,128Top 20%
GW Glaxo Wellcome: 1 patents #211 of 449Top 50%
GL Glaxosmithkline: 1 patents #290 of 646Top 45%
📍 Horsham, GB: #30 of 159 inventorsTop 20%
Overall (All Time): #731,304 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
9604981 IP receptor agonist heterocyclic compounds Rebecca Butler, Catherine Leblanc, Steven John Charlton 2017-03-28
9174985 Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists Catherine Leblanc, Anett Perlberg, Nicola Tufilli 2015-11-03
9132127 Substituted pyrido[2,3-B]pyrazines as IP receptor agonists Steven John Charlton, Catherine Leblanc 2015-09-15
9115129 Substituted pyrido[2,3-B]pyrazines as IP receptor agonists Steven John Charlton, Catherine Leblanc 2015-08-25
8754085 Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist Steven John Charlton, Catherine Leblanc 2014-06-17
7834013 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40 David F. Corbett, Kate Anna Dwornik, Dulce Maria Garrido, Wendy Yoon Mills, Andrew James Peat +1 more 2010-11-16
6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors George Stuart Cockerill, Stephen Barry Guntrip, Martin Page, Kathryn Jane Smith, Sadie Vile +3 more 2001-01-02